Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgit C P Koch

Showing results (1-10 of 205) with videos related to

Pageof 21
Sort By:
Antibiotics (Basel, Switzerland)|August 26, 2023
Clinical Experience with Off-Label Intrathecal Administration of Selected Antibiotics in Adults: An Overview with Pharmacometric ConsiderationsAnouk E Muller, Peter van Vliet, Birgit C P Koch
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|February 17, 2022
DiffErenCes in AntihypertenSive Drug Blood Levels in Patients with HypertensiON (DECISION): Protocol for a Prospective Observational Study Comparing Pharmacokinetics and Pharmacodynamics Between Young and Elderly PatientsDimokrat Hassan, Laura E J Peeters, Birgit C P Koch, et al.
The Journal of Antimicrobial Chemotherapy|March 20, 2024
Towards optimizing cefepime/tazobactam (WCK 4282) exposure to achieve efficacy against piperacillin/tazobactam-resistant ESBL infections: dose recommendations for various renal functions, including intermittent haemodialysis, in healthy individualsAnouk E Muller, Brenda C M De Winter, Birgit C P Koch
Clinical Pharmacokinetics|February 8, 2026
Methodologies for Population Pharmacokinetic Modeling of Target-Site Drug Exposure: A Narrative Review of Current StrategiesMichelle Mehciz, Pascale C S Rietveld, Birgit C P Koch, et al.
Therapeutic Drug Monitoring|May 18, 2023
Stability of 10 Beta-Lactam Antibiotics in Human Plasma at Different Storage ConditionsSoma Bahmany, Tim M J Ewoldt, Alan Abdulla, et al.
Therapeutic Drug Monitoring|April 18, 2014
Using fluorescence polarization immunoassay for determination of erythrocyte methotrexate polyglutamates, a quick and easy test?Ethan den Boer, Birgit C P Koch, Ruud Huisman, et al.
British Journal of Clinical Pharmacology|June 7, 2024
'Under pressure': The role of therapeutic drug monitoring in the treatment of hypertensionJorie Versmissen, Job van Steenkiste, Birgit C P Koch, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 5, 2019
[Use of antipsychotics in children; too much or too long?]Sanne M Kloosterboer, Birgit C P Koch, Manon H J Hillegers, et al.
Frontiers in Pharmacology|December 27, 2021
The Pharmacokinetics of Beta-Lactam Antibiotics Using Scavenged Samples in Pediatric Intensive Care Patients: The EXPAT Kids Study ProtocolStef Schouwenburg, Enno D Wildschut, M de Hoog, et al.
Journal of Clinical Psychopharmacology|April 24, 2026
Imipramine: Do Metabolite Plasma Levels Affect Treatment Response?Roan Y N Kasanmonadi, Astrid M Kamperman, Birgit C P Koch, et al.
Pageof 21

Showing results (1-10 of 205) with videos related to

Sort By:
Pageof 21
Antibiotics (Basel, Switzerland)|August 26, 2023
Clinical Experience with Off-Label Intrathecal Administration of Selected Antibiotics in Adults: An Overview with Pharmacometric ConsiderationsAnouk E Muller, Peter van Vliet, Birgit C P Koch
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|February 17, 2022
DiffErenCes in AntihypertenSive Drug Blood Levels in Patients with HypertensiON (DECISION): Protocol for a Prospective Observational Study Comparing Pharmacokinetics and Pharmacodynamics Between Young and Elderly PatientsDimokrat Hassan, Laura E J Peeters, Birgit C P Koch, et al.
The Journal of Antimicrobial Chemotherapy|March 20, 2024
Towards optimizing cefepime/tazobactam (WCK 4282) exposure to achieve efficacy against piperacillin/tazobactam-resistant ESBL infections: dose recommendations for various renal functions, including intermittent haemodialysis, in healthy individualsAnouk E Muller, Brenda C M De Winter, Birgit C P Koch
Clinical Pharmacokinetics|February 8, 2026
Methodologies for Population Pharmacokinetic Modeling of Target-Site Drug Exposure: A Narrative Review of Current StrategiesMichelle Mehciz, Pascale C S Rietveld, Birgit C P Koch, et al.
Therapeutic Drug Monitoring|May 18, 2023
Stability of 10 Beta-Lactam Antibiotics in Human Plasma at Different Storage ConditionsSoma Bahmany, Tim M J Ewoldt, Alan Abdulla, et al.
Therapeutic Drug Monitoring|April 18, 2014
Using fluorescence polarization immunoassay for determination of erythrocyte methotrexate polyglutamates, a quick and easy test?Ethan den Boer, Birgit C P Koch, Ruud Huisman, et al.
British Journal of Clinical Pharmacology|June 7, 2024
'Under pressure': The role of therapeutic drug monitoring in the treatment of hypertensionJorie Versmissen, Job van Steenkiste, Birgit C P Koch, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 5, 2019
[Use of antipsychotics in children; too much or too long?]Sanne M Kloosterboer, Birgit C P Koch, Manon H J Hillegers, et al.
Frontiers in Pharmacology|December 27, 2021
The Pharmacokinetics of Beta-Lactam Antibiotics Using Scavenged Samples in Pediatric Intensive Care Patients: The EXPAT Kids Study ProtocolStef Schouwenburg, Enno D Wildschut, M de Hoog, et al.
Journal of Clinical Psychopharmacology|April 24, 2026
Imipramine: Do Metabolite Plasma Levels Affect Treatment Response?Roan Y N Kasanmonadi, Astrid M Kamperman, Birgit C P Koch, et al.
Pageof 21